{"id":"https://openalex.org/W1994924048","doi":"https://doi.org/10.1185/03007991003673617","title":"Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population","display_name":"Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population","alternate_titles":[],"publication_year":2010,"publication_date":"2010-02-23","ids":{"openalex":"https://openalex.org/W1994924048","doi":"https://doi.org/10.1185/03007991003673617","mag":"1994924048","pmid":"https://pubmed.ncbi.nlm.nih.gov/20178404"},"language":"en","primary_location":{"id":"doi:10.1185/03007991003673617","doi":"https://doi.org/10.1185/03007991003673617","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007991003673617","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1994924048"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111794861","display_name":"Laura Christensen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Laura Christensen","raw_affiliation_strings":["i3 Innovus, Ann Arbor, MI","i3 Innovus, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"i3 Innovus, Ann Arbor, MI","institution_ids":[]},{"raw_affiliation_string":"i3 Innovus, Ann Arbor, MI, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050998332","display_name":"Rahul Sasan\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Rahul Sasan\u00e9","raw_affiliation_strings":["Shire Pharmaceuticals, Wayne, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire Pharmaceuticals, Wayne, PA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113890775","display_name":"Paul Hodgkins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul Hodgkins","raw_affiliation_strings":["Shire Pharmaceuticals, Wayne, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire Pharmaceuticals, Wayne, PA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078029213","display_name":"Carolyn Harley","orcid":"https://orcid.org/0000-0002-4003-8316","observed_orcids":["https://orcid.org/0000-0002-4003-8316"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carolyn Harley","raw_affiliation_strings":["i3 Innovus, Palo Alto, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"i3 Innovus, Palo Alto, CA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111602029","display_name":"Srinivas Tetali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Srinivas Tetali","raw_affiliation_strings":["Shire Pharmaceuticals, Wayne, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire Pharmaceuticals, Wayne, PA","institution_ids":["https://openalex.org/I4210140176"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5050998332"],"corresponding_institution_ids":["https://openalex.org/I4210140176"],"apc_list":null,"apc_paid":null,"fwci":5.9639,"has_fulltext":false,"cited_by_count":94,"citation_normalized_percentile":{"value":0.96716739,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"26","issue":"4","first_page":"977","last_page":"989"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9990000128746033},{"id":"https://openalex.org/keywords/medication-persistence","display_name":"treatment persistence","score":0.7559999823570251},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.9520000219345093},{"id":"https://openalex.org/keywords/stimulant-medication","display_name":"stimulant medication","score":0.6330000162124634},{"id":"https://openalex.org/keywords/atomoxetine","display_name":"atomoxetine","score":0.6620000004768372},{"id":"https://openalex.org/keywords/amphetamine","display_name":"amphetamine","score":0.7860000133514404},{"id":"https://openalex.org/keywords/methylphenidate","display_name":"methylphenidate","score":0.9929999709129333},{"id":"https://openalex.org/keywords/long-acting-formulations","display_name":"long-acting formulations","score":0.7310000061988831},{"id":"https://openalex.org/keywords/dose-changes","display_name":"dose changes","score":0.699999988079071},{"id":"https://openalex.org/keywords/drug-switching","display_name":"drug switching","score":0.9760000109672546},{"id":"https://openalex.org/keywords/medication-augmentation","display_name":"medication augmentation","score":0.7160000205039978},{"id":"https://openalex.org/keywords/claims-data-analysis","display_name":"claims data analysis","score":0.6230000257492065},{"id":"https://openalex.org/keywords/children-and-adolescents","display_name":"children and adolescents","score":0.6169999837875366},{"id":"https://openalex.org/keywords/duration-of-action","display_name":"duration of action","score":0.6679999828338623},{"id":"https://openalex.org/keywords/treatment-stability","display_name":"treatment stability","score":0.40700000524520874}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9034382104873657},{"id":"https://openalex.org/C2780557958","wikidata":"https://www.wikidata.org/wiki/Q211036","display_name":"Stimulant","level":2,"score":0.8073165416717529},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.7967096567153931},{"id":"https://openalex.org/C2778781522","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine","level":4,"score":0.7018064856529236},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.6036221981048584},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.5643064975738525},{"id":"https://openalex.org/C99476002","wikidata":"https://www.wikidata.org/wiki/Q42297","display_name":"Analysis of variance","level":2,"score":0.5451887845993042},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5269944071769714},{"id":"https://openalex.org/C2778176773","wikidata":"https://www.wikidata.org/wiki/Q2976049","display_name":"Drug class","level":3,"score":0.5170503258705139},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.5010521411895752},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.49030283093452454},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4898662269115448},{"id":"https://openalex.org/C2781009140","wikidata":"https://www.wikidata.org/wiki/Q7170389","display_name":"Persistence (discontinuity)","level":2,"score":0.45218297839164734},{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.4103849530220032},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.38772499561309814},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3492286205291748},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3410717844963074},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3277628421783447},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2040632665157318},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.09094735980033875},{"id":"https://openalex.org/C187320778","wikidata":"https://www.wikidata.org/wiki/Q1349130","display_name":"Geotechnical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069445","descriptor_name":"Atomoxetine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000661","descriptor_name":"Amphetamine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006279","descriptor_name":"Health Maintenance Organizations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008694","descriptor_name":"Methamphetamine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011437","descriptor_name":"Propylamines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017723","descriptor_name":"Drug Utilization Review","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055118","descriptor_name":"Medication Adherence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1185/03007991003673617","doi":"https://doi.org/10.1185/03007991003673617","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007991003673617","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},{"id":"pmid:20178404","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20178404","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W128328154","https://openalex.org/W201300076","https://openalex.org/W1965064658","https://openalex.org/W1966223858","https://openalex.org/W1970966565","https://openalex.org/W1972571048","https://openalex.org/W1979206088","https://openalex.org/W2018245820","https://openalex.org/W2022330640","https://openalex.org/W2043761192","https://openalex.org/W2046837347","https://openalex.org/W2049846947","https://openalex.org/W2049863677","https://openalex.org/W2062714266","https://openalex.org/W2097767249","https://openalex.org/W2111135575","https://openalex.org/W2114290463","https://openalex.org/W2129168200","https://openalex.org/W2140918476","https://openalex.org/W2145425766","https://openalex.org/W2148237638","https://openalex.org/W2160487182","https://openalex.org/W2161431517","https://openalex.org/W2163322724","https://openalex.org/W2164116088","https://openalex.org/W2171074660","https://openalex.org/W2171204232","https://openalex.org/W2197133068","https://openalex.org/W2285134444","https://openalex.org/W2914686075","https://openalex.org/W4206601757","https://openalex.org/W4240979396"],"related_works":["https://openalex.org/W2113114472","https://openalex.org/W2148237638","https://openalex.org/W2409127462","https://openalex.org/W2063452698","https://openalex.org/W2398492757","https://openalex.org/W2101379036","https://openalex.org/W2893979568","https://openalex.org/W2515269559","https://openalex.org/W1969504415","https://openalex.org/W4324350346"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"develop":[2],"a":[3,67,73,168,264,267,296,299,330],"descriptive":[4],"profile":[5],"of":[6,15,39,111,125,270],"attention-deficit/hyperactivity":[7],"disorder":[8],"(ADHD)":[9],"pharmacological":[10],"treatment":[11,28,57,318],"patterns":[12,29,58],"in":[13,27],"terms":[14],"persistence,":[16],"adherence,":[17],"augmentation,":[18],"switching,":[19,103],"and":[20,23,37,52,72,93,104,123,140,175,192,200,229,236,292],"dosing":[21],"changes;":[22],"to":[24,32,55,261],"assess":[25],"differences":[26],"with":[30,61,66,263,266,320],"regard":[31],"ADHD":[33,71,77],"medication":[34,78,102,237,257,278,307],"type,":[35],"class,":[36],"duration":[38,124,269],"action.":[40],"METHODS:":[41],"This":[42,282],"retrospective":[43],"claims":[44,291],"database":[45],"analysis":[46],"used":[47],"medical":[48],"data,":[49,51],"pharmacy":[50],"enrollment":[53],"information":[54],"examine":[56],"among":[59,214,242],"patients":[60,154,180,187,194],"at":[62,108],"least":[63,212],"one":[64],"claim":[65,297],"diagnosis":[68],"code":[69],"for":[70,76,138,149,179,186,193,298],"filled":[74],"prescription":[75,300],"(index":[79],"therapy)":[80],"during":[81],"the":[82,135,144,184,217,306],"period":[83],"01":[84],"January":[85],"2004":[86],"through":[87],"30":[88],"September":[89],"2006.":[90],"Treatment":[91],"persistence":[92],"adherence":[94,176],"(days":[95],"supplied/days":[96],"persistent)":[97],"were":[98,106,132,159,166,177,211,239,258,314],"calculated.":[99],"Dose":[100],"changes,":[101],"augmentation":[105],"analyzed":[107],"three":[109],"levels":[110],"comparison:":[112],"class":[113],"(stimulant":[114],"vs":[115,121],"nonstimulant":[116,218],"[atomoxetine]),":[117],"drug":[118,208,265],"type":[119],"(amphetamine":[120],"methylphenidate),":[122],"action":[126,271],"(short,":[127],"intermediate,":[128],"long).":[129],"Statistical":[130],"comparisons":[131],"made":[133],"using":[134],"chi-square":[136],"test":[137],"proportions":[139],"Student's":[141],"t-test":[142],"or":[143,224,247,276,334],"F-test":[145],"from":[146],"one-way":[147],"ANOVA":[148],"means.":[150],"RESULTS:":[151],"Of":[152],"60,010":[153],"meeting":[155],"eligibility":[156],"criteria,":[157],"58.4%":[158],"younger":[160],"than":[161,272],"age":[162],"18.":[163],"Most":[164],"(78.4%)":[165],"prescribed":[167],"stimulant":[169],"as":[170,310],"their":[171,321,326],"index":[172,327],"therapy.":[173],"Persistence":[174],"greater":[178],"on":[181,188,195,244,317],"stimulants":[182],"(vs":[183,190,198,219,222,227],"nonstimulant),":[185],"amphetamines":[189],"methylphenidates),":[191],"long-acting":[196,230,256,332],"medications":[197],"short-":[199,228],"intermediate-acting":[201,225],"medications;":[202],"all":[203,232],"p":[204,233,251],"<":[205,234,252,280],"0.0001).":[206,253,281],"Index":[207],"dose":[209],"changes":[210],"likely":[213,260],"individuals":[215],"taking":[216,255,274],"stimulants),":[220],"methylphenidates":[221],"amphetamines),":[223],"drugs":[226,249],"drugs;":[231],"0.0001),":[235],"switches":[238],"more":[240,315],"frequent":[241],"those":[243,273],"nonstimulants,":[245],"methylphenidates,":[246],"short-acting":[248,277],"(all":[250],"Subjects":[254],"less":[259],"augment":[262],"different":[268],"intermediate-":[275],"(p":[279],"claims-based":[283],"study":[284],"is":[285],"limited":[286],"by":[287],"possible":[288],"discrepancies":[289],"between":[290],"patient":[293],"behaviors":[294],"(i.e.,":[295],"does":[301],"not":[302],"necessarily":[303],"indicate":[304],"that":[305],"was":[308,329],"taken":[309],"prescribed).":[311],"CONCLUSIONS:":[312],"Patients":[313],"stable":[316],"compared":[319],"respective":[322],"comparator":[323],"groups":[324],"if":[325],"therapy":[328],"stimulant,":[331],"drug,":[333],"amphetamine.":[335]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1994924048","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":15}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
